{"count": 3, "results": [{"_id": "37513826", "pmid": 37513826, "pmcid": "PMC10385015", "title": "The Potential Therapeutic Application of Simvastatin for Brain Complications and Mechanisms of Action", "journal": "Pharmaceuticals (Basel)", "authors": ["Vuu YM", "Kadar Shahib A", "Rastegar M"], "date": "2023-06-22T00:00:00Z", "doi": "10.3390/ph16070914", "meta_date_publication": "2023 Jun 22", "meta_volume": "16", "meta_issue": "7", "meta_pages": "", "score": 50273.117, "text_hl": "Recent studies have suggested that @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ could be a promising therapeutic option for different @DISEASE_Brain_Diseases @DISEASE_MESH:D001927 @@@brain complications@@@ and diseases ranging from @DISEASE_Brain_Neoplasms @DISEASE_MESH:D001932 @@@brain tumors@@@ (i.e., @DISEASE_Medulloblastoma @DISEASE_MESH:D008527 @@@medulloblastoma@@@ and @DISEASE_Glioblastoma @DISEASE_MESH:D005909 @@@glioblastoma@@@) to @DISEASE_Neurologic_Manifestations @DISEASE_MESH:D009461 @@@neurological disorders@@@ (i.e., @DISEASE_Alzheimer_Disease @DISEASE_MESH:D000544 @@@Alzheimer's disease@@@, @DISEASE_Parkinson_Disease @DISEASE_MESH:D010300 @@@Parkinson's disease@@@, and @<m>DISEASE_Huntington_Disease</m> @DISEASE_MESH:D006816 @@@Huntington's disease@@@). ", "citations": {"NLM": "Vuu YM, Kadar Shahib A, Rastegar M. The Potential Therapeutic Application of Simvastatin for Brain Complications and Mechanisms of Action Pharmaceuticals (Basel). 2023 Jun 22;16(7):. PMID: 37513826", "BibTeX": "@article{37513826, title={The Potential Therapeutic Application of Simvastatin for Brain Complications and Mechanisms of Action}, author={Vuu YM and Kadar Shahib A and Rastegar M}, journal={Pharmaceuticals (Basel)}, volume={16}, number={7}}"}}, {"_id": "20663016", "pmid": 20663016, "title": "Altered cholesterol homeostasis contributes to enhanced excitotoxicity in Huntington's disease.", "journal": "J Neurochem", "authors": ["del Toro D", "Xifró X", "Pol A", "Humbert S", "Saudou F", "Canals JM", "Alberch J"], "date": "2010-10-01T00:00:00Z", "doi": "10.1111/j.1471-4159.2010.06912.x", "meta_date_publication": "2010 Oct", "meta_volume": "115", "meta_issue": "1", "meta_pages": "153-67", "score": 50062.516, "text_hl": "Administration of drugs that recover this effect, such as @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ could be beneficial for the treatment of @<m>DISEASE_Huntington_Disease</m> @DISEASE_MESH:D006816 @@@HD@@@.", "citations": {"NLM": "del Toro D, Xifró X, Pol A, Humbert S, Saudou F, Canals JM, Alberch J. Altered cholesterol homeostasis contributes to enhanced excitotoxicity in Huntington's disease. J Neurochem. 2010 Oct;115(1):153-67. PMID: 20663016", "BibTeX": "@article{20663016, title={Altered cholesterol homeostasis contributes to enhanced excitotoxicity in Huntington's disease.}, author={del Toro D and Xifró X and Pol A and Humbert S and Saudou F and Canals JM and Alberch J}, journal={J Neurochem}, volume={115}, number={1}, pages={153-67}}"}}, {"_id": "15012690", "pmid": 15012690, "title": "C-reactive protein as a cardiovascular risk factor and its therapeutic implications in end-stage renal disease patients.", "journal": "Nephrology (Carlton)", "authors": ["Park JS", "Kim SB"], "date": "2003-10-01T00:00:00Z", "doi": "10.1046/j.1440-1797.8.s.8.x", "meta_date_publication": "2003 Oct", "meta_volume": "8 Suppl", "meta_issue": "", "meta_pages": "S40-4", "score": 50036.625, "text_hl": "We found that @CHEMICAL_Aspirin @CHEMICAL_MESH:D001241 @@@aspirin@@@ 200 mg daily for 8 weeks induce no significant changes of the @GENE_CRP @GENE_1401 @@@CRP@@@ levels in @DISEASE_Peritonitis @DISEASE_MESH:D010538 @@@PD@@@ @SPECIES_9606 @@@patients@@@ (0.22 vs. 0.18 mg/dL, p > 0.05). However, 62 @<m>DISEASE_Huntington_Disease</m> @DISEASE_MESH:D006816 @@@HD@@@ @SPECIES_9606 @@@patients@@@ were randomly assigned to treatment group (@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ 20 mg/day) and control group. ", "citations": {"NLM": "Park JS, Kim SB. C-reactive protein as a cardiovascular risk factor and its therapeutic implications in end-stage renal disease patients. Nephrology (Carlton). 2003 Oct;8 Suppl():S40-4. PMID: 15012690", "BibTeX": "@article{15012690, title={C-reactive protein as a cardiovascular risk factor and its therapeutic implications in end-stage renal disease patients.}, author={Park JS and Kim SB}, journal={Nephrology (Carlton)}, volume={8 Suppl}, pages={S40-4}}"}}]}